Tranche Update on Master Pharm SA's Equity Buyback Plan announced on June 24, 2020.

Master Pharm SA is a Poland-based company primarily engaged in the manufacture of wellbeing products. The Company specializes in designing and producing diet supplements, food for special nutritional purposes, dietary products, cosmetics, medical devices, as well as other consumables for third parties. Its activities are divided into four operating areas: Contract manufacturing, including designing technology and ingredients of products, manufacturing, packaging, labeling, and marking, among others; Preparation of product documentation, providing product specification, certificate of ingredients and technical etiquette; Import-export, trading with raw materials and food supplements, and Medical Devices, offering medical device design, tests, documentation, and registration. The Company cooperates with Adamed, Bioton, Synoptis, Polpharma, Pharmena, and Salvum, among others. The main shareholder of the Company is Max Welt Holdings Ltd.